Gill Heart and Vascular Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.
Curr Cardiol Rep. 2022 Nov;24(11):1755-1763. doi: 10.1007/s11886-022-01784-4. Epub 2022 Sep 12.
Acute coronary syndromes (ACS) often occur in individuals with prior coronary artery bypass graft surgery (CABG). Our goal was to describe the prevalence, clinical characteristics, prognosis, and treatment strategies in this group of patients.
Studies demonstrate that both acute and long-term major adverse cardiovascular outcomes are increased in patients with ACS and prior CABG compared to those without CABG. Much of this risk is attributed to the greater comorbid conditions present in patients with prior CABG. Data regarding optimal management of ACS in patients with prior CABG are limited, but most observational studies favor an early invasive approach for treatment. Native vessel percutaneous coronary intervention (PCI), if feasible, is generally preferred to bypass graft PCI. Patients with ACS and prior CABG represent a high-risk group of individuals, and implementing optimal preventive and treatment strategies are critically important to reduce the risk.
急性冠状动脉综合征(ACS)常发生于冠状动脉旁路移植术(CABG)后的患者。我们的目的是描述该类患者的患病率、临床特征、预后和治疗策略。
研究表明,与未行 CABG 的患者相比,ACS 合并 CABG 的患者的急性和长期主要心血管不良事件发生率均增加。这主要归因于 CABG 患者合并的疾病更多。有关 CABG 后 ACS 的最佳管理的数据有限,但大多数观察性研究倾向于早期采用介入治疗。如果可行,优先选择经皮冠状动脉介入治疗(PCI)而非旁路移植术 PCI。ACS 合并 CABG 的患者属于高危人群,实施最佳的预防和治疗策略对于降低风险至关重要。